Relation between CYP2D6 polymorphisms and survival in breast cancer treated with tamoxifen
| dc.conference.date | SEP 19-OCT 18, 2020 | |
| dc.conference.title | ESMO Virtual Congress | |
| dc.contributor.author | Rubio Novella, S. | |
| dc.contributor.author | Blancas Lopez-Barajas, M. I. | |
| dc.contributor.author | Ochoa, E. | |
| dc.contributor.author | Herrero Vicent, C. | |
| dc.contributor.author | Olmos, S. | |
| dc.contributor.author | Martinez Duenas, E. | |
| dc.contributor.authoraffiliation | [Rubio Novella, S.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain | |
| dc.contributor.authoraffiliation | [Ochoa, E.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain | |
| dc.contributor.authoraffiliation | [Herrero Vicent, C.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain | |
| dc.contributor.authoraffiliation | [Olmos, S.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain | |
| dc.contributor.authoraffiliation | [Martinez Duenas, E.] Hosp Prov Castellon, Med Oncol, Castellon de La Plana, Spain | |
| dc.contributor.authoraffiliation | [Blancas Lopez-Barajas, M. I.] Hosp Clin San Cecilio, Dept Med Oncol, Granada, Spain | |
| dc.date.accessioned | 2025-01-07T13:59:04Z | |
| dc.date.available | 2025-01-07T13:59:04Z | |
| dc.date.issued | 2020-09-01 | |
| dc.identifier.doi | 10.1016/j.annonc.2020.08.321 | |
| dc.identifier.essn | 1569-8041 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753420403175/pdf | |
| dc.identifier.uri | https://hdl.handle.net/10668/26022 | |
| dc.identifier.wosID | 573469100199 | |
| dc.issue.number | 4 | |
| dc.journal.title | Annals of oncology | |
| dc.journal.titleabbreviation | Ann. oncol. | |
| dc.language.iso | en | |
| dc.organization | SAS - Hospital Universitario San Cecilio | |
| dc.organization | SAS - Hospital Universitario San Cecilio | |
| dc.page.number | S322-S322 | |
| dc.publisher | Elsevier | |
| dc.rights.accessRights | open access | |
| dc.title | Relation between CYP2D6 polymorphisms and survival in breast cancer treated with tamoxifen | |
| dc.type | conference output | |
| dc.type.hasVersion | VoR | |
| dc.volume.number | 31 | |
| dc.wostype | Meeting Abstract |